These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 50290)

  • 1. Soluble tumour-specific antigen and its relationship to tumour growth.
    Thomson DM
    Int J Cancer; 1975 Jun; 15(6):1016-29. PubMed ID: 50290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours.
    Embleton MJ
    Int J Cancer; 1976 Nov; 18(5):622-9. PubMed ID: 791870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata.
    Thomson DM; Steele K; Alexander P
    Br J Cancer; 1973 Jan; 27(1):27-34. PubMed ID: 4568460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.
    Thomson DM; Sellens V; Eccles S; Alexander P
    Br J Cancer; 1973 Nov; 28(5):377-88. PubMed ID: 4758368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological aspects of rat tumour xenograft growth in athymic nude mice.
    Pimm MV; Baldwin RW
    Br J Cancer; 1979 Feb; 39(2):116-21. PubMed ID: 373782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
    Embleton MJ; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG immunotherapy of a rat sarcoma.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Oct; 28(4):281-7. PubMed ID: 4759936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen weight in rats during tumour growth and in homograft rejection.
    Blamey RW; Evans DM
    Br J Cancer; 1971 Sep; 25(3):527-32. PubMed ID: 4947347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells.
    Yagello M; Lespinats G; Fridman WH
    Int J Cancer; 1978 Aug; 22(2):136-41. PubMed ID: 359487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of H-2 antigen and immunogenicity of methylcholanthrene-induced murine sarcomas.
    Pearson T; Sikora K; Lennox E
    Br J Cancer; 1978 Apr; 37(4):530-5. PubMed ID: 77161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-killed BCG in the treatment of transplanted rat tumours.
    Baldwin RW; Cook AJ; Hopper DG; Pimm MV
    Int J Cancer; 1974 Jun; 13(6):743-50. PubMed ID: 4369104
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata.
    Thomson DM; Eccles S; Alexander P
    Br J Cancer; 1973 Jul; 28(1):6-15. PubMed ID: 4579634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.